Login / Signup

HER3 Augmentation via Blockade of EGFR/AKT Signaling Enhances Anticancer Activity of HER3-Targeting Patritumab Deruxtecan in EGFR-Mutated Non-Small Cell Lung Cancer.

Kimio YonesakaJunko TanizakiOsamu MaenishiKoji HarataniHiasto KawakamiKaoru TanakaHidetoshi HayashiKazuko SakaiYasutaka ChibaAsuka TsuyaHiroki GotoEri OtsukaHiroaki OkidaMaki KobayashiRyoto YoshimotoMasanori FunabashiYuuri HashimotoKenji HirotaniTakashi KagariKazuto NishioKazuhiko Nakagawa
Published in: Clinical cancer research : an official journal of the American Association for Cancer Research (2021)
-mutated NSCLC.
Keyphrases
  • small cell lung cancer
  • epidermal growth factor receptor
  • tyrosine kinase
  • advanced non small cell lung cancer
  • brain metastases
  • signaling pathway
  • cell proliferation
  • wild type
  • cancer therapy
  • soft tissue